Zdrowie i gospodarka · 04/02/2003

FDA Withdraws Draft Guidance on Electronic Records and Signatures

The Food and Drug Administration (FDA) has withdrawn its draft guidance on electronic records and signatures, which was set to provide industry guidance on the use of electronic records and electronic signatures in the pharmaceutical industry.